Company: SHPH
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001493152-25-002253
Chunk: 162

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-01-15
Form: S-1
Chunk 162
---
| Total Stockholders’ Equity (Deficit)                                                     |     |               |  (1,315,377 | ) |     |              |   4,055,771 |   |
| Total Liabilities and Stockholders’ Equity (Deficit)                                     |     | $             |     673,568 |   |     | $            |   5,951,736 |   |

<div align='center'>The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</div>

| F-2 |

<div align='center'>Shuttle Pharmaceuticals Holdings, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)</div>

|                                                                                                               |     |               2024 |            |   |     | 2023 |            |   |     |              2024 |            |   |     | 2023 |            |   |
|                                                                                                               |     | Three Months Ended |            |   |     |      |            |   |     | Nine Months Ended |            |   |     |      |            |   |
|                                                                                                               |     |      September 30, |            |   |     |      |            |   |     |     September 30, |            |   |     |      |            |   |
|                                                                                                               |     |               2024 |            |   |     | 2023 |            |   |     |              2024 |            |   |     | 2023 |            |   |
| Revenue                                                                                                       |     |                  $ |          - |   |     |    $ |          - |   |     |                 $ |          - |   |     |    $ |          - |   |
| Operating expenses                                                                                            |     |                    |            |   |     |      |            |   |     |                   |            |   |     |      |            |   |
| Research and development                                                                                      |     |                    |  1,400,564 |   |     |      |  1,045,177 |   |     |                   |  2,632,387 |   |     |      |  2,806,644 |   |
| General and administrative                                                                                    |     |                    |    328,995 |   |     |      |    265,553 |   |     |                   |    963,642 |   |     |      |    730,186 |